Discovery Labs Provides Business and Pipeline Development Update
04 nov. 2009 08h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) is providing an update on its strategic business activities and its KL4 surfactant pipeline clinical...
Discovery Labs Schedules Conference Call and Webcast
30 oct. 2009 16h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call on Wednesday, November 4, 2009 at 4:00 PM EST. Management will provide...
Discovery Labs and FDA Establish Path for Potential Surfaxin Approval
30 sept. 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) held a teleconference on September 29, 2009 with the U.S. Food and Drug Administration (FDA). The meeting...
Discovery Labs and FDA to Meet On September 29, 2009 to Discuss Potential Path for SURFAXIN Approval
10 sept. 2009 16h17 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) has received written notification from the U.S. Food and Drug Administration (FDA) that a meeting has...
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
04 sept. 2009 16h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Sept. 4, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biotechnology company developing its proprietary KL4 surfactant technology to improve respiratory...
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
13 août 2009 18h42 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Aug. 13, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biotechnology company developing its proprietary KL4 surfactant technology to improve respiratory...
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
29 juil. 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 29, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today is announcing financial results for the second quarter ended June 30, 2009 and is providing an...
Discovery Labs Schedules Conference Call and Webcast
23 juil. 2009 08h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 23, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be hosting a conference call on Wednesday, July 29, 2009 at 10:00 AM EDT. Management will provide an...
Discovery Labs Reports On Surfaxin End of Review Meeting With FDA
01 juil. 2009 17h02 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 1, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces today, after receipt of written minutes from the United States Food and Drug Administration, the...
Discovery Labs Announces Completion of $11.3 Million Registered Direct Offering
13 mai 2009 16h05 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 13, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has completed its previously announced registered direct offering of 14 million...